Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 6

1.

The Cross-Talk Between TGF-β and Periostin Can Be Targeted for Pulmonary Fibrosis.

Nanri Y, Nunomura S, Terasaki Y, Yoshihara T, Hirano Y, Yokosaki Y, Yamaguchi Y, Feghali-Bostwick C, Ajito K, Murakami S, Conway SJ, Izuhara K.

Am J Respir Cell Mol Biol. 2019 Sep 10. doi: 10.1165/rcmb.2019-0245OC. [Epub ahead of print]

PMID:
31505128
2.

Correction to: Cardiovascular Risks, Bleeding Risks, and Clinical Events from 3 Phase III Trials of Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis.

Glassberg MK, Nathan SD, Lin CY, Morgenthien EA, Stauffer JL, Chou W, Noble PW.

Adv Ther. 2019 Sep 9. doi: 10.1007/s12325-019-01082-6. [Epub ahead of print]

PMID:
31502216
3.

TM4SF5-mediated CD44v8-10 splicing variant promotes survival of type II alveolar epithelial cells during idiopathic pulmonary fibrosis.

Kim JE, Kim HJ, Jung JW, Song DG, Park D, Lee H, Um H, Park J, Nam SH, Cho M, Lee JW.

Cell Death Dis. 2019 Sep 9;10(9):645. doi: 10.1038/s41419-019-1878-5.

4.

[The clinical experience of pirfenidone based on corticosteroids and immunosuppressant treatment for interstitial pneumonia with autoimmune features].

Huang H, Sun YX, Li S, Shao C, Xu K, Xu ZJ.

Zhonghua Jie He He Hu Xi Za Zhi. 2019 Sep 12;42(9):700-704. doi: 10.3760/cma.j.issn.1001-0939.2019.09.009. Chinese.

PMID:
31484245
5.

[Interference research of umbilical cord mesenchymal stem cells on the pulmonary fibrosis in silicosis rats].

Sha Y, Xie Y, Chen ZJ, Yang XY, Luo J, Zhang BL, Zhang X, Ji X, Li ZM.

Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi. 2019 Jun 20;37(6):401-407. doi: 10.3760/cma.j.issn.1001-9391.2019.06.001. Chinese.

PMID:
31256519

Supplemental Content

Loading ...
Support Center